Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found potential new targets for treating melanoma and nonmelanoma skin cancers, and identified a possible cause and treatment for male pattern baldness and eczema.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Researchers identified genes in scalp hair follicles that may affect hair traits and hair loss.

Forensic DNA Phenotyping accurately predicts physical traits and is used in investigations, but needs more diverse population data for confirmation.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Older adults commonly experience hair loss and nail disorders due to aging and health changes, affecting their quality of life.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

Androgenetic alopecia, or hair loss, is most common in people in their 30s, can start early, is often inherited, and may be influenced by factors like hormones and scalp health.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

PCOS often causes skin issues like excess hair, acne, hair thinning, and dark patches due to hormone imbalances and insulin resistance.

Consider rare forms of CAH for accurate diagnosis and treatment.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

Hair growth serums A and C can affect hair growth genes and pathways, suggesting potential for personalized hair loss treatments.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Androgenetic alopecia is more common in Saudi men than women.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

New hair loss treatments could be improved by using combined biological markers.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.

Society's pressure to have children later in life favors genes that increase the risk of early baldness in male offspring.

Some treatments like minoxidil, finasteride, and surgery can help with hereditary hair loss.

Certain genetic markers and low vitamin D3 levels are linked to male pattern baldness.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

Androgenic alopecia, or male pattern baldness, is caused by genes.

Male pattern hair loss is common, affects mental health, and can be treated with medication or hair transplants.